Annual SGA
$274.52 M
+$46.83 M+20.56%
December 31, 2023
Summary
- As of February 7, 2025, SAGE annual SGA is $274.52 million, with the most recent change of +$46.83 million (+20.56%) on December 31, 2023.
- During the last 3 years, SAGE annual SGA has risen by +$77.57 million (+39.39%).
- SAGE annual SGA is now -20.61% below its all-time high of $345.78 million, reached on December 31, 2019.
Performance
SAGE SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$53.22 M
-$2.76 M-4.94%
September 30, 2024
Summary
- As of February 7, 2025, SAGE quarterly SGA is $53.22 million, with the most recent change of -$2.76 million (-4.94%) on September 30, 2024.
- Over the past year, SAGE quarterly SGA has dropped by -$2.76 million (-4.94%).
- SAGE quarterly SGA is now -39.87% below its all-time high of $88.50 million, reached on September 30, 2019.
Performance
SAGE Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$10.90 B
-$337.59 M-3.20%
September 30, 2024
Summary
- As of February 7, 2025, SAGE TTM SGA is -$10.90 billion, with the most recent change of -$337.59 million (-3.20%) on September 30, 2024.
- Over the past year, SAGE TTM SGA has dropped by -$11.15 billion (-4609.09%).
- SAGE TTM SGA is now -34322.55% below its all-time high of -$31.68 million.
Performance
SAGE TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
SAGE Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.6% | -4.9% | -4609.1% |
| 3 y3 years | +39.4% | +9.3% | -5981.1% |
| 5 y5 years | +36.3% | -39.9% | -3253.3% |
SAGE Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +49.6% | -31.9% | +14.5% | -108.1% | at low |
| 5 y | 5-year | -20.6% | +49.6% | -37.5% | +51.6% | -128.0% | at low |
| alltime | all time | -20.6% | >+9999.0% | -39.9% | +6544.1% | <-9999.0% | at low |
Sage Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $53.22 M(-4.9%) | $216.88 M(-10.3%) |
| Jun 2024 | - | $55.98 M(+6.5%) | $241.81 M(-7.5%) |
| Mar 2024 | - | $52.57 M(-4.6%) | $261.39 M(-4.8%) |
| Dec 2023 | $274.52 M(+20.6%) | $55.11 M(-29.5%) | $274.52 M(-4.3%) |
| Sep 2023 | - | $78.14 M(+3.4%) | $286.74 M(+6.2%) |
| Jun 2023 | - | $75.56 M(+15.0%) | $270.08 M(+8.0%) |
| Mar 2023 | - | $65.71 M(-2.4%) | $250.06 M(+8.3%) |
| Dec 2022 | $227.70 M(+24.1%) | $67.33 M(+9.5%) | $230.83 M(+7.3%) |
| Sep 2022 | - | $61.48 M(+10.7%) | $215.10 M(+6.3%) |
| Jun 2022 | - | $55.55 M(+19.5%) | $202.33 M(+6.4%) |
| Mar 2022 | - | $46.48 M(-9.9%) | $190.13 M(+3.6%) |
| Dec 2021 | $183.50 M(-6.8%) | $51.60 M(+5.9%) | $183.50 M(-1.0%) |
| Sep 2021 | - | $48.71 M(+12.4%) | $185.40 M(+7.9%) |
| Jun 2021 | - | $43.35 M(+8.8%) | $171.79 M(+3.1%) |
| Mar 2021 | - | $39.85 M(-25.5%) | $166.67 M(-15.4%) |
| Dec 2020 | $196.95 M(-43.0%) | $53.50 M(+52.4%) | $196.95 M(-13.8%) |
| Sep 2020 | - | $35.10 M(-8.2%) | $228.58 M(-18.9%) |
| Jun 2020 | - | $38.22 M(-45.5%) | $281.99 M(-15.1%) |
| Mar 2020 | - | $70.13 M(-17.6%) | $331.99 M(-4.0%) |
| Dec 2019 | $345.78 M(+71.7%) | $85.13 M(-3.8%) | $345.78 M(+2.8%) |
| Sep 2019 | - | $88.50 M(+0.3%) | $336.34 M(+11.5%) |
| Jun 2019 | - | $88.23 M(+5.1%) | $301.53 M(+17.6%) |
| Mar 2019 | - | $83.92 M(+10.9%) | $256.47 M(+27.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $201.40 M(+220.3%) | $75.69 M(+41.0%) | $201.40 M(+38.6%) |
| Sep 2018 | - | $53.69 M(+24.4%) | $145.27 M(+34.9%) |
| Jun 2018 | - | $43.17 M(+49.6%) | $107.66 M(+35.5%) |
| Mar 2018 | - | $28.85 M(+47.5%) | $79.45 M(+26.4%) |
| Dec 2017 | $62.88 M(+59.6%) | $19.56 M(+21.6%) | $62.88 M(+9.0%) |
| Sep 2017 | - | $16.09 M(+7.6%) | $57.70 M(+14.0%) |
| Jun 2017 | - | $14.95 M(+21.8%) | $50.60 M(+13.6%) |
| Mar 2017 | - | $12.28 M(-14.6%) | $44.55 M(+13.1%) |
| Dec 2016 | $39.41 M(+55.8%) | $14.37 M(+59.9%) | $39.41 M(+18.5%) |
| Sep 2016 | - | $8.99 M(+0.9%) | $33.27 M(+7.7%) |
| Jun 2016 | - | $8.91 M(+24.9%) | $30.88 M(+8.6%) |
| Mar 2016 | - | $7.13 M(-13.4%) | $28.43 M(+12.4%) |
| Dec 2015 | $25.29 M(+160.5%) | $8.24 M(+24.7%) | $25.29 M(+23.5%) |
| Sep 2015 | - | $6.60 M(+2.3%) | $20.47 M(+22.3%) |
| Jun 2015 | - | $6.46 M(+61.5%) | $16.74 M(+38.5%) |
| Mar 2015 | - | $4.00 M(+17.0%) | $12.09 M(+24.5%) |
| Dec 2014 | $9.71 M(+147.6%) | $3.42 M(+19.1%) | $9.71 M(+29.5%) |
| Sep 2014 | - | $2.87 M(+58.8%) | $7.50 M(+30.6%) |
| Jun 2014 | - | $1.81 M(+11.8%) | $5.74 M(+21.3%) |
| Mar 2014 | - | $1.62 M(+34.4%) | $4.73 M(+51.9%) |
| Dec 2013 | $3.92 M(+63.3%) | $1.20 M(+8.3%) | $3.12 M(+62.9%) |
| Sep 2013 | - | $1.11 M(+38.7%) | $1.91 M(+138.7%) |
| Jun 2013 | - | $801.00 K | $801.00 K |
| Dec 2012 | $2.40 M | - | - |
FAQ
- What is Sage Therapeutics annual SGA?
- What is the all time high annual SGA for Sage Therapeutics?
- What is Sage Therapeutics annual SGA year-on-year change?
- What is Sage Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Sage Therapeutics?
- What is Sage Therapeutics quarterly SGA year-on-year change?
- What is Sage Therapeutics TTM SGA?
- What is the all time high TTM SGA for Sage Therapeutics?
- What is Sage Therapeutics TTM SGA year-on-year change?
What is Sage Therapeutics annual SGA?
The current annual SGA of SAGE is $274.52 M
What is the all time high annual SGA for Sage Therapeutics?
Sage Therapeutics all-time high annual SGA is $345.78 M
What is Sage Therapeutics annual SGA year-on-year change?
Over the past year, SAGE annual SGA has changed by +$46.83 M (+20.56%)
What is Sage Therapeutics quarterly SGA?
The current quarterly SGA of SAGE is $53.22 M
What is the all time high quarterly SGA for Sage Therapeutics?
Sage Therapeutics all-time high quarterly SGA is $88.50 M
What is Sage Therapeutics quarterly SGA year-on-year change?
Over the past year, SAGE quarterly SGA has changed by -$2.76 M (-4.94%)
What is Sage Therapeutics TTM SGA?
The current TTM SGA of SAGE is -$10.90 B
What is the all time high TTM SGA for Sage Therapeutics?
Sage Therapeutics all-time high TTM SGA is -$31.68 M
What is Sage Therapeutics TTM SGA year-on-year change?
Over the past year, SAGE TTM SGA has changed by -$11.15 B (-4609.09%)